Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanisms and Predictions of Interindividual Variability in Drug Pharmacokinetics and Adverse Drug Reactions

Award Number: R35GM161276
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2026
PERIOD OF PERFORMANCE END DATE: 04/30/2031

Group Awards By:

View Award Description

Mechanisms and Predictions of Interindividual Variability in Drug Pharmacokinetics and Adverse Drug Reactions - Predictions of drug disposition and toxicity from preclinical data, estimation of risk of drug-drug interactions and simulation of drug exposures in humans are essential for safe and effective drug development and clinical pharmacology. Despite decades of research, significant gaps still remain in translating preclinical findings to clinical drug development and practice. As a result, about 90% of drug candidates that enter Phase I clinical trials fail during development. In addition, uncertainty regarding the disposition characteristics of approved drugs often remains after drug approval leading to post marketing studies and label revisions. This wastes resources, leads to unnecessary risk to patients and limits access to life saving medications for specific patient populations. My laboratory works to bridge the knowledge gaps in translational science via mechanistic in vitro studies, mass spectrometry based proteomics experiments and state-of-the art in silico modeling. We develop novel proteomics methods to understand formation of drug adducts by small molecule drugs, evaluate how drug-protein and protein-protein interactions within a cell alter drug distribution and the activity of drug metabolizing enzymes, and assess how genetic variability and individual biology such as sex, disease and age alter drug exposures in tissues and in blood. Central questions of my research program include: What mechanisms cause significant under and overpredictions of drug exposures and drug-drug interactions in humans? Which individual factors define interindividual variability in drug-protein adduct formation making certain individuals highly susceptible? What mechanisms lead to changes in drug clearance in specific populations and between individuals? Answering these questions will advance developing individualized therapy and enable connecting observable patient specific factors with decisions of drug dosage adjustments. Our long term goal is to improve the preclinical, translational and computational methodologies used to predict and evaluate drug disposition and adverse drug reactions. Our current studies are focused on 1) development of innovative proteomic methods for discovery, characterization and quantification of protein adducts in simple and complex biological matrices; 2) evaluation of the role of fatty acid binding proteins in modulating tissue drug distribution and drug clearance and 3) developing novel physiologically based pharmacokinetic models to predict drug disposition in specific populations including vulnerable patients. Our studies advance innovative areas such as how intracellular binding proteins influence drug efficacy, and provide unprecedented insight into mechanisms of enzyme inactivation and quantitative relationships between adduct formation and metabolic activity in the liver. Our research will also provide open and accessible cutting-edge tools for high-dimensional proteomics data and novel PBPK models for prediction of drug disposition in specific patient populations. Our work promises to decrease failure rate during drug development and lead to expanded access to approved medications in specific patient groups through improved quantitative systems biology approaches.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $388,750 )
2026	2026	UNIVERSITY OF WASHINGTON	4333 BROOKLYN AVE NE	SEATTLE	WA	98195	KING	USA	Biomedical Research and Research Training	000	1	3/20/2026	NEW	$388,750
														Subtotal = $388,750

Grand Total All Awards = $388,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms and Predictions of Interindividual Variability in Drug Pharmacokinetics and Adverse Drug Reactions

Award Number: R35GM161276

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2026

PERIOD OF PERFORMANCE END DATE: 04/30/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer